These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6153566

  • 21. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
    Kan-Mitchell J, White WL, Mitchell MS.
    Cancer Res; 1989 Aug 15; 49(16):4536-41. PubMed ID: 2472881
    [Abstract] [Full Text] [Related]

  • 22. Immunotherapy in patients with oral malignant disease.
    Perlin E.
    Otolaryngol Clin North Am; 1979 Feb 15; 12(1):195-9. PubMed ID: 440739
    [No Abstract] [Full Text] [Related]

  • 23. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ, Dohlsten M, Lando PA, Kalland T, Ohlsson L, Andersson J, Andersson U.
    Eur J Immunol; 1996 Jan 15; 26(1):1-9. PubMed ID: 8566049
    [Abstract] [Full Text] [Related]

  • 24. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM.
    Cancer Res; 1979 Feb 15; 39(2 Pt 2):627-9. PubMed ID: 83917
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
    Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A.
    J Exp Med; 1998 Jan 19; 187(2):265-70. PubMed ID: 9432985
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer.
    Hanna MG.
    Hum Vaccin Immunother; 2012 Aug 19; 8(8):1156-60. PubMed ID: 22854664
    [Abstract] [Full Text] [Related]

  • 32. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
    Unfer RC, Hellrung D, Link CJ.
    Cancer Res; 2003 Mar 01; 63(5):987-93. PubMed ID: 12615713
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Purification of tumor-specific antigens. An overview of the relevance to human colon carcinoma.
    Kahan BD, Tom BH, Mokyr MB, Rutzky LP, Pellis NR.
    Cancer; 1975 Dec 01; 36(6 Suppl):2449-54. PubMed ID: 1212663
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Experimental and clinical studies with active specific immunotherapy.
    Livingston PO.
    Prog Clin Biol Res; 1989 Dec 01; 288():309-21. PubMed ID: 2654953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.